228 related articles for article (PubMed ID: 29460097)
1. Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients.
Bunevicius A; Radziunas A; Tamasauskas S; Tamasauskas A; Laws ER; Iervasi G; Bunevicius R; Deltuva V
J Neurooncol; 2018 Jun; 138(2):351-358. PubMed ID: 29460097
[TBL] [Abstract][Full Text] [Related]
2. Serum Levels of APRIL Increase in Patients with Glioma, Meningioma and Schwannoma.
Fouladseresht H; Ziaee SM; Erfani N; Doroudchi M
Asian Pac J Cancer Prev; 2019 Mar; 20(3):751-756. PubMed ID: 30909681
[TBL] [Abstract][Full Text] [Related]
3. Common genetic variations of deiodinase genes and prognosis of brain tumor patients.
Bunevicius A; Laws ER; Saudargiene A; Tamasauskas A; Iervasi G; Deltuva V; Smith TR; Bunevicius R
Endocrine; 2019 Dec; 66(3):563-572. PubMed ID: 31452060
[TBL] [Abstract][Full Text] [Related]
4. Role of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and inteleukin-6 in predicting a poor outcome after a stroke.
Bunevicius A; Kazlauskas H; Raskauskiene N; Mickuviene N; Ndreu R; Corsano E; Bunevicius R
Neuroimmunomodulation; 2015; 22(6):365-72. PubMed ID: 25967464
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of VEGF, FGF and PDGF and Serum Levels of Inflammatory Cytokines in Patients with Glioma and Meningioma in Southern Iran.
Shamsdin SA; Mehrafshan A; Rakei SM; Mehrabani D
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2883-2890. PubMed ID: 31653130
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of serum vitronectin levels in human glioma.
Chen MH; Lu C; Sun J; Chen XD; Dai JX; Cai JY; Chen XL
J Neurol Sci; 2016 Dec; 371():54-59. PubMed ID: 27871448
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum IL-17A but not IL-6 in glioma versus meningioma and schwannoma.
Doroudchi M; Pishe ZG; Malekzadeh M; Golmoghaddam H; Taghipour M; Ghaderi A
Asian Pac J Cancer Prev; 2013; 14(9):5225-30. PubMed ID: 24175805
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
9. Personality traits, patient-centered health status and prognosis of brain tumor patients.
Bunevicius A
J Neurooncol; 2018 May; 137(3):593-600. PubMed ID: 29327173
[TBL] [Abstract][Full Text] [Related]
10. Atypical meningioma. A study on recurrence and disease-specific survival.
Champeaux C; Houston D; Dunn L
Neurochirurgie; 2017 Sep; 63(4):273-281. PubMed ID: 28882609
[TBL] [Abstract][Full Text] [Related]
11. Preoperative N-terminal pro-B-type natriuretic peptide concertation and prognosis of brain tumor patients: a 5-year follow up study.
Bunevicius A; Deltuva V; Laws ER; Iervasi G; Tamsauskas A; Bunevicius R
Sci Rep; 2017 Nov; 7(1):14775. PubMed ID: 29116209
[TBL] [Abstract][Full Text] [Related]
12. Preoperative low tri-iodothyronine concentration is associated with worse health status and shorter five year survival of primary brain tumor patients.
Bunevicius A; Deltuva VP; Tamasauskas S; Smith T; Laws ER; Bunevicius R; Iervasi G; Tamasauskas A
Oncotarget; 2017 Jan; 8(5):8648-8656. PubMed ID: 28055959
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
Gandhi P; Khare R; Garg N
J Neurooncol; 2017 Nov; 135(2):255-261. PubMed ID: 28756592
[TBL] [Abstract][Full Text] [Related]
14. Circulating Levels of Thrombospondin-1 and Thrombospondin-2 in Patients with Common Brain Tumors.
Kemerdere R; Akgun MY; Toklu S; Aydin S; Orhan B; Inal BB; Korkmaz TS; Aktas B; Kacira T; Tanriverdi T
Turk Neurosurg; 2021; 31(3):399-403. PubMed ID: 33759165
[TBL] [Abstract][Full Text] [Related]
15. IL-10 and PRKDC polymorphisms are associated with glioma patient survival.
Hu M; Du J; Cui L; Huang T; Guo X; Zhao Y; Ma X; Jin T; Li G; Song J
Oncotarget; 2016 Dec; 7(49):80680-80687. PubMed ID: 27811370
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma.
Strojnik T; Smigoc T; Lah TT
Anticancer Res; 2014 Jan; 34(1):339-47. PubMed ID: 24403485
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Biological Correlates of Preoperative Cognitive Functioning of Glioma and Meningioma Patients.
Pranckeviciene A; Deltuva VP; Tamasauskas A; Zegliene J; Bunevicius A
Biomed Res Int; 2020; 2020():2054859. PubMed ID: 32461966
[TBL] [Abstract][Full Text] [Related]
18. Predictive significance of plasma levels of interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgery.
Ucar HI; Tok M; Atalar E; Dogan OF; Oc M; Farsak B; Guvener M; Yilmaz M; Dogan R; Demircin M; Pasaoglu I
Heart Surg Forum; 2007; 10(2):E131-5. PubMed ID: 17597037
[TBL] [Abstract][Full Text] [Related]
19. Exploratory investigation of eight circulating plasma markers in brain tumor patients.
Ilhan-Mutlu A; Wagner L; Widhalm G; Wöhrer A; Bartsch S; Czech T; Heinzl H; Leutmezer F; Prayer D; Marosi C; Base W; Preusser M
Neurosurg Rev; 2013 Jan; 36(1):45-55; discussion 55-6. PubMed ID: 22763625
[TBL] [Abstract][Full Text] [Related]
20. Quantification of fibrin degradation products in glioma and meningioma patients.
Can O; Erdemgil Y; Yildirim ZZ; Ozduman K; Pamir MN; Sav A; Ozpinar A
Cancer Biomark; 2014; 14(4):253-8. PubMed ID: 24934368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
